. 2013 Jul 25;7(7):e2328. doi: 10.1371/journal.pntd.0002328

Table 3. Phenotypic profile of innate immunity subsets.

Cell Phenotypes^*	Clinical Groups
	Control			HTLV-1⁺
	All	L⁽⁻⁾	L⁽⁺⁾	All	L⁽⁻⁾	L⁽⁺⁾
CD14⁺ CD16⁺/CD14⁺	8.5±2.2	8.8±2.7	8.1±1.6	12.3±5.7^a	11.3±5.0	12.8±6.1^c
CD14⁺CD16⁺HLADR⁺⁺/CD14⁺CD16⁺	65.5±13.7	65.4±12.6	65.7±15.4	50.5±15.9^a	49.5±13.1^b	50.9±17.4^c
CD3⁻CD16^−/+CD56^−/+/CD3⁻	10.7±4.1	11.5±4.6	10.0±3.8	18.2±8.3^a	18.6±6.0^b	18.1±19.2^c
CD3⁺CD16^−/+CD56^−/+/CD3⁺	0.5±0.3	0.6±0.2	0.4±2.1	0.9±0.7^a	0.6±0.2	1.0±0.2^c
CD4⁺CD25^HIGH	1.9±1.3	2.2±1.7	1.7±1.1	1.9±1.2	1.9±1.0	1.9±1.3

Monocyte subsets, NK-cells and NKT-cells and Regulatory T-cells in the peripheral blood of HTLV-1-infected patients and uninfected controls according to the absence (L⁽⁻⁾) or presence (L⁽⁺⁾) of dermatological Lesions.

Data are expressed as mean percentage (%) ± standard error of cell phenotype within a selected gated cell subset shown after the slash, except for CD3⁻CD16^−/+CD56^−/+ and CD4⁺CD25^HIGH that were analyzed within gated lymphocytes.

Significant differences at P<0.05 are highlighted by letter “a”, “b” and “c” for difference between pairs of subgroups “All”, L⁽⁻⁾ and L⁽⁺⁾, respectively.